Search

everythinglearnresearchcommunity

for

Search:↓

Scientists found gene mutations that affect hair loss, skin stem cells, and skin disorders, and identified drugs that may help treat blood vessel and skin conditions.

Many women's hair loss is due to health issues, medication, nutrition, or stress.

Male pattern hair loss is common, affects mental health, and can be treated with medication or hair transplants.

Hair loss in older men is linked to higher rates of diabetes and high blood pressure.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

Androgenic alopecia is a type of hair loss that's partly inherited and can be due to hormonal imbalance.

Early hair loss may signal a risk for metabolic syndrome and related health issues.

Finasteride effectively treats male pattern baldness.

Female hair loss is influenced by genetics and hormones, often starting in middle age or after hormonal changes.

Treating hair loss effectively may require a multi-sided approach, using different treatments together, and topical treatments could be more effective and safer than oral ones.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

The emulgel with specific ingredients was effective for treating hair loss.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

Both genetics and lifestyle factors contribute to male pattern baldness.

Early treatment with finasteride and minoxidil can effectively reverse hereditary hair loss.

Early intervention and continuous treatment are key for managing hereditary hair loss effectively.

Hair loss in women is often due to hereditary conditions or stress, and while treatments like minoxidil can help, diagnosis and management require medical guidance.

The document explains different hair and scalp conditions, including common hair loss after pregnancy or illness, drug-induced hair loss, hereditary excessive hair growth, patterned baldness, autoimmune hair loss, and permanent loss due to skin disease, with generally limited treatment options.

Minoxidil and finasteride are key treatments for hair loss.

The document concludes that hair loss in women is treated with medications, therapies, and surgery in Western medicine, and with acupuncture and herbs in Chinese medicine, but hereditary hair loss is hard to reverse.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

A new food supplement was highly effective in curing hair loss in young men.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Stem cell therapies show promise for hair regrowth but face production and application challenges.

Androgenetic alopecia is the most common hair loss, more severe in men, and best treated with a combination of hair growth promoters and antiandrogens.

Caffeine in Alpecin shampoo may help prolong hair root activity and reduce hair loss.

Light therapy may improve eye conditions by stimulating cell activity and increasing oxygen availability.

Topical minoxidil showed promise for early male pattern baldness.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.